83_FR_16184 83 FR 16112 - Office of the Director, National Institutes of Health; Notice of Meeting

83 FR 16112 - Office of the Director, National Institutes of Health; Notice of Meeting

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 83, Issue 72 (April 13, 2018)

Page Range16112-16113
FR Document2018-07757

Federal Register, Volume 83 Issue 72 (Friday, April 13, 2018) 
[Federal Register Volume 83, Number 72 (Friday, April 13, 2018)]
[Notices]
[Pages 16112-16113]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2018-07757]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Office of the Director, National Institutes of Health; Notice of 
Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the meeting of the Council of 
Councils.
    The meeting will be open to the public as indicated below, with 
attendance limited to space available. Individuals who plan to attend 
and need special assistance, such as sign language interpretation or 
other reasonable accommodations, should notify the Contact Person 
listed below in advance of the meeting. The open session will be 
videocast and can be accessed from the NIH Videocasting and Podcasting 
website (http://videocast.nih.gov).
    A portion of the meeting will be closed to the public in accordance 
with the provisions set forth in sections 552b(c)(4), and 552b(c)(6), 
Title 5 U.S.C., as amended. The grant applications and the discussions 
could disclose confidential trade secrets or commercial property such 
as patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: Council of Councils.
    Open: May 18, 2018.
    Time: 8:15 a.m. to 11:30 a.m.
    Agenda: Call to Order and Introductions; Announcements and 
Updates; Evaluating the ``Broadening Experiences in Scientific 
Training (BEST)'' Awards; NIDA Update; Introduction to the Use of 
Non-Human Primates (NHP) in Addiction Research; NHP Models of Drug 
Addiction.
    Place: National Institutes of Health, 9000 Rockville Pike, 
Building 31, C Wing, 6th Floor, Conference Room 10, Bethesda, MD 
20892.

    Closed: May 18, 2018.
    Time: 12:30 p.m. to 2:30 p.m.
    Agenda: Review of Grant Applications.
    Place: National Institutes of Health, 9000 Rockville Pike, 
Building 31, C Wing, 6th Floor, Conference Room 10, Bethesda, MD 
20892.

    Open: May 18, 2018.
    Time: 2:30 p.m. to 4:05 p.m.
    Agenda: Division of Program Coordination, Planning, and 
Strategic Initiatives (DPCPSI) Program Presentations; Update from 
the Office of Portfolio Analysis; Closing Remarks.
    Place: National Institutes of Health, 9000 Rockville Pike, 
Building 31, C Wing, 6th Floor, Conference Room 10, Bethesda, MD 
20892.
    Contact Person: Franziska Grieder, D.V.M., Ph.D., Executive 
Secretary, Director, Office of Research Infrastructure Programs, 
Division of Program Coordination, Planning, and Strategic 
Initiatives, Office of the Director, NIH, 6701 Democracy Boulevard, 
Room 948, Bethesda, MD 20892, [email protected], 301-435-0744.

    Any interested person may file written comments with the 
committee by forwarding the statement to the Contact Person listed 
on this notice. The statement should include the name, address, 
telephone number and when applicable, the business or professional 
affiliation of the interested person.
    In the interest of security, NIH has instituted stringent 
procedures for entrance onto the NIH campus. All visitor vehicles, 
including taxicabs, hotel, and airport shuttles will be inspected 
before being allowed on campus. Visitors will be asked to show one 
form of identification (for example, a

[[Page 16113]]

government-issued photo ID, driver's license, or passport) and to 
state the purpose of their visit.
    Information is also available on the Council of Council's home 
page at http://dpcpsi.nih.gov/council/ where an agenda will be 
posted before the meeting date.

(Catalogue of Federal Domestic Assistance Program Nos. 93.14, 
Intramural Research Training Award; 93.22, Clinical Research Loan 
Repayment Program for Individuals from Disadvantaged Backgrounds; 
93.232, Loan Repayment Program for Research Generally; 93.39, 
Academic Research Enhancement Award; 93.936, NIH Acquired 
Immunodeficiency Syndrome Research Loan Repayment Program; 93.187, 
Undergraduate Scholarship Program for Individuals from Disadvantaged 
Backgrounds, National Institutes of Health, HHS)

    Dated: April 10, 2018.
David D. Clary,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2018-07757 Filed 4-12-18; 8:45 am]
 BILLING CODE 4140-01-P

16112 Federal Register / Vol. 83, No. 72 / Friday, April 13, 2018 / Notices 0910–0120 and the collections of DEPARTMENT OF HEALTH AND notify the Contact Person listed below information in 21 CFR part 814, HUMAN SERVICES in advance of the meeting. The open subparts A through E, have been session will be videocast and can be approved under OMB control number National Institutes of Health accessed from the NIH Videocasting and 0910–0231. Podcasting website (http://videocast. National Institute on Minority Health nih.gov). Dated: April 9, 2018. and Health Disparities; Notice of A portion of the meeting will be Leslie Kux, Closed Meeting closed to the public in accordance with Associate Commissioner for Policy. Pursuant to section 10(d) of the the provisions set forth in sections [FR Doc. 2018–07686 Filed 4–12–18; 8:45 am] 552b(c)(4), and 552b(c)(6), Title 5 Federal Advisory Committee Act, as BILLING CODE 4164–01–P amended, notice is hereby given of the U.S.C., as amended. The grant following meeting. applications and the discussions could The meeting will be closed to the disclose confidential trade secrets or DEPARTMENT OF HEALTH AND commercial property such as patentable HUMAN SERVICES public in accordance with the provisions set forth in sections material, and personal information National Institutes of Health 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., concerning individuals associated with as amended. The grant applications and the grant applications, the disclosure of National Center for Advancing the discussions could disclose which would constitute a clearly Translational Sciences; Notice of confidential trade secrets or commercial unwarranted invasion of personal Closed Meeting property such as patentable materials, privacy. and personal information concerning Name of Committee: Council of Councils. Pursuant to section 10(d) of the individuals associated with the grant Open: May 18, 2018. Federal Advisory Committee Act, as applications, the disclosure of which Time: 8:15 a.m. to 11:30 a.m. amended, notice is hereby given of the would constitute a clearly unwarranted Agenda: Call to Order and Introductions; following meeting. invasion of personal privacy. Announcements and Updates; Evaluating the ‘‘Broadening Experiences in Scientific The meeting will be closed to the Name of Committee: National Institute on Training (BEST)’’ Awards; NIDA Update; public in accordance with the Minority Health and Health Disparities Introduction to the Use of Non-Human provisions set forth in sections Special Emphasis Panel; Prevention and Primates (NHP) in Addiction Research; NHP 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Treatment Research to Address HIV/AIDS Models of Drug Addiction. as amended. The grant applications and Disparities in Woman in the U.S. Place: National Institutes of Health, 9000 the discussions could disclose Date: May 24, 2018. Rockville Pike, Building 31, C Wing, 6th confidential trade secrets or commercial Time: 12:30 p.m. to 5:30 p.m. Floor, Conference Room 10, Bethesda, MD property such as patentable material, Agenda: To review and evaluate grant 20892. applications. Closed: May 18, 2018. and personal information concerning Place: Gateway Building, 7201 Wisconsin individuals associated with the grant Time: 12:30 p.m. to 2:30 p.m. Ave., Suite 533, Bethesda, MD 20814 Agenda: Review of Grant Applications. applications, the disclosure of which (Telephone Conference Call). Place: National Institutes of Health, 9000 would constitute a clearly unwarranted Contact Person: Maryline Laude-Sharp, Rockville Pike, Building 31, C Wing, 6th invasion of personal privacy. Ph.D., Scientific Review Officer, National Floor, Conference Room 10, Bethesda, MD Name of Committee: National Center for Institute on Minority Health and Health 20892. Advancing Translational Sciences Special Disparities, National Institutes of Health, Open: May 18, 2018. Emphasis Panel; New Therapeutic Uses. 7201 Wisconsin Ave., Bethesda, MD 20814, Time: 2:30 p.m. to 4:05 p.m. Date: June 6, 2018. (301) 451–9536, mlaudesharp@nih.gov. Agenda: Division of Program Coordination, Time: 8:00 a.m. to 5:00 p.m. Dated: April 10, 2018. Planning, and Strategic Initiatives (DPCPSI) Agenda: To review and evaluate grant David D. Clary, Program Presentations; Update from the applications. Office of Portfolio Analysis; Closing Remarks. Program Analyst, Office of Federal Advisory Place: National Institutes of Health, 9000 Place: National Institutes of Health, One Committee Policy. Rockville Pike, Building 31, C Wing, 6th Democracy Plaza, Room 1066, 6701 Democracy Boulevard, Bethesda, MD 20892 [FR Doc. 2018–07755 Filed 4–12–18; 8:45 am] Floor, Conference Room 10, Bethesda, MD (Virtual Meeting). BILLING CODE 4140–01–P 20892. Contact Person: Barbara J. Nelson, Ph.D., Contact Person: Franziska Grieder, D.V.M., Scientific Review Officer, Office of Scientific Ph.D., Executive Secretary, Director, Office of Review, National Center for Advancing DEPARTMENT OF HEALTH AND Research Infrastructure Programs, Division of Translational Sciences (NCATS), National HUMAN SERVICES Program Coordination, Planning, and Institutes of Health 6701 Democracy Blvd., Strategic Initiatives, Office of the Director, Democracy 1, Room 1080, Bethesda, MD National Institutes of Health NIH, 6701 Democracy Boulevard, Room 948, 20892–4874, 301–435–0806, nelsonbj@ Bethesda, MD 20892, GriederF@mail.nih.gov, mail.nih.gov. Office of the Director, National 301–435–0744. (Catalogue of Federal Domestic Assistance Institutes of Health; Notice of Meeting Any interested person may file written Program Nos. 93.859, Pharmacology, comments with the committee by forwarding Physiology, and Biological Chemistry Pursuant to section 10(d) of the the statement to the Contact Person listed on Research; 93.350, B–Cooperative Agreements; Federal Advisory Committee Act, as this notice. The statement should include the 93.859, Biomedical Research and Research amended, notice is hereby given of the name, address, telephone number and when Training, National Institutes of Health, HHS) meeting of the Council of Councils. applicable, the business or professional daltland on DSKBBV9HB2PROD with NOTICES The meeting will be open to the affiliation of the interested person. Dated: April 10, 2018. In the interest of security, NIH has public as indicated below, with David D. Clary, instituted stringent procedures for entrance attendance limited to space available. onto the NIH campus. All visitor vehicles, Program Analyst, Office of Federal Advisory Individuals who plan to attend and including taxicabs, hotel, and airport shuttles Committee Policy. need special assistance, such as sign will be inspected before being allowed on [FR Doc. 2018–07753 Filed 4–12–18; 8:45 am] language interpretation or other campus. Visitors will be asked to show one BILLING CODE 4140–01–P reasonable accommodations, should form of identification (for example, a VerDate Sep<11>2014 17:41 Apr 12, 2018 Jkt 244001 PO 00000 Frm 00069 Fmt 4703 Sfmt 4703 E:\FR\FM\13APN1.SGM 13APN1

Federal Register / Vol. 83, No. 72 / Friday, April 13, 2018 / Notices 16113 government-issued photo ID, driver’s license, Review Branch, OERA, 7201 Wisconsin Ave., (Catalogue of Federal Domestic Assistance or passport) and to state the purpose of their Suite 525, Bethesda, MD 20814, (301) 594– Program No.: 93.279, Drug Abuse and visit. 7784, Xinli.Nan@nih.gov. Addiction Research Programs, National Information is also available on the Institutes of Health, HHS) Council of Council’s home page at http:// Dated: April 10, 2018. Dated: April 10, 2018. dpcpsi.nih.gov/council/ where an agenda David D. Clary, will be posted before the meeting date. Natasha M. Copeland, Program Analyst, Office of Federal Advisory (Catalogue of Federal Domestic Assistance Committee Policy. Program Analyst, Office of Federal Advisory Program Nos. 93.14, Intramural Research Committee Policy. [FR Doc. 2018–07756 Filed 4–12–18; 8:45 am] Training Award; 93.22, Clinical Research [FR Doc. 2018–07754 Filed 4–12–18; 8:45 am] BILLING CODE 4140–01–P Loan Repayment Program for Individuals BILLING CODE 4140–01–P from Disadvantaged Backgrounds; 93.232, Loan Repayment Program for Research Generally; 93.39, Academic Research DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND Enhancement Award; 93.936, NIH Acquired HUMAN SERVICES Immunodeficiency Syndrome Research Loan Repayment Program; 93.187, Undergraduate National Institutes of Health National Institutes of Health Scholarship Program for Individuals from Disadvantaged Backgrounds, National National Institute on Drug Abuse; Notice of Closed Meetings Center for Scientific Review; Notice of Institutes of Health, HHS) Closed Meetings Dated: April 10, 2018. Pursuant to section 10(d) of the David D. Clary, Federal Advisory Committee Act, as Pursuant to section 10(d) of the Program Analyst, Office of Federal Advisory amended, notice is hereby given of the Federal Advisory Committee Act, as Committee Policy. following meetings. amended, notice is hereby given of the [FR Doc. 2018–07757 Filed 4–12–18; 8:45 am] The meetings will be closed to the following meetings. public in accordance with the The meetings will be closed to the BILLING CODE 4140–01–P provisions set forth in sections public in accordance with the 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., provisions set forth in sections DEPARTMENT OF HEALTH AND as amended. The contract proposals and 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., HUMAN SERVICES the discussions could disclose as amended. The grant applications and confidential trade secrets or commercial the discussions could disclose National Institutes of Health property such as patentable material, confidential trade secrets or commercial and personal information concerning property such as patentable material, National Institute on Minority Health individuals associated with the contract and personal information concerning and Health Disparities; Notice of proposals, the disclosure of which individuals associated with the grant Closed Meeting would constitute a clearly unwarranted applications, the disclosure of which invasion of personal privacy. would constitute a clearly unwarranted Pursuant to section 10(d) of the invasion of personal privacy. Federal Advisory Committee Act, as Name of Committee: National Institute on amended, notice is hereby given of the Drug Abuse Special Emphasis Panel; Name of Committee: Center for Scientific following meeting. Synthesis and Distribution of Drugs of Abuse Review Special Emphasis Panel; Chronic The meeting will be closed to the and Related Compounds (8944). Disease in the Caribbean-II. public in accordance with the Date: April 24, 2018. Date: April 16, 2018. Time: 10:00 a.m. to 1:00 p.m. Time: 3:00 p.m. to 3:30 p.m. provisions set forth in sections Agenda: To review and evaluate grant Agenda: To review and evaluate contract 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., proposals. applications. as amended. The grant applications and Place: National Institutes of Health, Place: National Institutes of Health, 6701 the discussions could disclose Neuroscience Center, 6001 Executive Rockledge Drive, Bethesda, MD 20892 confidential trade secrets or commercial Boulevard, Rockville, MD 20852 (Telephone (Telephone Conference Call). property such as patentable materials, Conference Call). Contact Person: Gniesha Yvonne and personal information concerning Contact Person: Lyle Furr, Scientific Dinwiddie, Ph.D., Scientific Review Officer, individuals associated with the grant Review Officer, Office of Extramural Affairs, Center for Scientific Review, National applications, the disclosure of which National Institute on Drug Abuse, NIH, Institutes of Health, 6701 Rockledge Drive, DHHS, Room 4227, MSC 9550, 6001 Room 3137, Bethesda, MD 20892, would constitute a clearly unwarranted Executive Boulevard, Bethesda, MD 20892– dinwiddiegy@csr.nih.gov. invasion of personal privacy. 9550, (301) 827–5702, lf33c.nih.gov. This notice is being published less Name of Committee: National Institute on Name of Committee: National Institute on than 15 days prior to the meeting due Minority Health and Health Disparities Drug Abuse Special Emphasis Panel; to the timing limitations imposed by the Special Emphasis Panel; Mechanisms of Toxicological Evaluations of Potential Disparities for HIV-Related Co-morbidities in review and funding cycle. Medications to Treat Drug Addiction (8939). Health Disparity Populations. Date: May 15, 2018. Name of Committee: Center for Scientific Date: May 30, 2018. Time: 10:00 a.m. to 1:00 p.m. Review Special Emphasis Panel; AIDS and Time: 12:00 p.m. to 5:00 p.m. Agenda: To review and evaluate contract Related Research Special Topic. Agenda: To review and evaluate grant proposals. Date: April 19, 2018. applications. Place: National Institutes of Health, Time: 11:00 a.m. to 1:00 p.m. Place: National Institute on Minority Neuroscience Center, 6001 Executive Agenda: To review and evaluate grant daltland on DSKBBV9HB2PROD with NOTICES Health and Health Disparities, 7201 Boulevard, Rockville, MD 20852 (Telephone applications. Wisconsin Ave., Suite 525, Rm. 533K, Conference Call). Place: National Institutes of Health, 6701 Bethesda, MD 20814 (Telephone Conference Contact Person: Lyle Furr, Scientific Rockledge Drive, Bethesda, MD 20892 Call). Review Officer, Office of Extramural Affairs, (Telephone Conference Call). Contact Person: Xinli Nan, Ph.D., Scientific National Institute on Drug Abuse, NIH, Contact Person: Robert Freund, Ph.D., Review Officer, National Institute on DHHS, Room 4227, MSC 9550, 6001 Scientific Review Officer, Center for Minority Health and Health Disparities, Executive Boulevard, Bethesda, MD 20892– Scientific Review, National Institutes of National Institutes of Health, Scientific 9550, (301) 827–5702, lf33c.nih.gov. Health, 6701 Rockledge Drive, Room 5216, VerDate Sep<11>2014 19:04 Apr 12, 2018 Jkt 244001 PO 00000 Frm 00070 Fmt 4703 Sfmt 4703 E:\FR\FM\13APN1.SGM 13APN1


Document Created: 2018-04-13 00:18:17
Document Modified: 2018-04-13 00:18:17
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
FR Citation83 FR 16112 
2024 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR